Adverse Reactions to Intravenous Iodinated Contrast Media: a Primer for Radiologists

Overview

Journal Emerg Radiol

Specialties Emergency Medicine
Radiology

Date 2006 May 12

PMID 16688432

Citations 49

Authors

Saravanan Namasivayam

Mannudeep K Kalra

William E Torres

William C Small

Affiliations

Soon will be listed here.

Abstract

Adverse reactions to intravenous iodinated contrast media may be classified as general and organ-specific, such as contrast-induced nephrotoxicity. General adverse reactions may be subclassified into acute and delayed types. Acute general adverse reactions can range from transient minor reactions to life-threatening severe reactions. Non-ionic contrast media have lower risk of mild and moderate adverse reactions. However, the risk of fatal reactions is similar for ionic and non-ionic contrast media. Adequate preprocedure evaluation should be performed to identify predisposing risk factors. Prompt recognition and treatment of acute adverse reactions is crucial. Risk of contrast induced nephrotoxicity can be reduced by use of non-ionic contrast media, less volume of contrast, and adequate hydration. The radiologist can play a pivotal role by being aware of predisposing factors, clinical presentation, and management of adverse reactions to contrast media.

Citing Articles

Transcatheter Aortic Valve Implantation (TAVI) Planning with Dual-Layer Spectral CT Using Virtual Monoenergetic Image (VMI) Reconstructions and 20 mL of Contrast Media.

Fontana F, Piacentino F, Gnesutta A, Macchi E, Coppola A, Saccomanno A J Clin Med. 2024; 13(2).

PMID: 38256659 PMC: 10816911. DOI: 10.3390/jcm13020524.

Medical Imaging Stewardship and Healthcare Savings: Utilization of Age Adjusted D-Dimer to Rule Out Acute Pulmonary Embolism.

Bloodworth P, Cail K, Morris C, Pando B, Helmly B HCA Healthc J Med. 2023; 2(4):297-301.

PMID: 37424849 PMC: 10324810. DOI: 10.36518/2689-0216.1219.

Deep anatomy learning for lung airway and artery-vein modeling with contrast-enhanced CT synthesis.

Zhang H, Zhang M, Gu Y, Yang G Int J Comput Assist Radiol Surg. 2023; 18(7):1287-1294.

PMID: 37259009 DOI: 10.1007/s11548-023-02946-7.

[Comparative Analysis of Image Quality and Adverse Events between Iopamidol 250 and Ioversol 320 in Hepatic Angiography for Transcatheter Arterial Chemoembolization].

Gu M, Yi J, Kim Y, Lee H, Kang U, Ji S Taehan Yongsang Uihakhoe Chi. 2022; 81(1):166-175.

PMID: 36238118 PMC: 9432096. DOI: 10.3348/jksr.2020.81.1.166.

Emergency pharmacology for the CT technologist.

Currie G J Med Radiat Sci. 2022; 70(1):81-94.

PMID: 36149085 PMC: 9977646. DOI: 10.1002/jmrs.620.

References

Thomsen H, Dorph S . High-osmolar and low-osmolar contrast media. An update on frequency of adverse drug reactions. Acta Radiol. 1993; 34(3):205-9. View

Siegle R, Halvorsen R, Dillon J, Gavant M, Halpern E . The use of iohexol in patients with previous reactions to ionic contrast material. A multicenter clinical trial. Invest Radiol. 1991; 26(5):411-6. DOI: 10.1097/00004424-199105000-00004. View

Webb J, Stacul F, Thomsen H, Morcos S . Late adverse reactions to intravascular iodinated contrast media. Eur Radiol. 2003; 13(1):181-4. DOI: 10.1007/s00330-002-1650-5. View

Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70. DOI: 10.7326/0003-4819-130-6-199903160-00002. View

Almen T . The etiology of contrast medium reactions. Invest Radiol. 1994; 29 Suppl 1:S37-45. View

Lin J, Bonventre J . Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens. 2005; 14(2):105-10. DOI: 10.1097/00041552-200503000-00004. View

Davies P, Roberts M, ROYLANCE J . Acute reactions to urographic contrast media. Br Med J. 1975; 2(5968):434-7. PMC: 1681828. DOI: 10.1136/bmj.2.5968.434. View

Lasser E, Berry C, Talner L, SANTINI L, Lang E, Gerber F . Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med. 1987; 317(14):845-9. DOI: 10.1056/NEJM198710013171401. View

Lasser E, Berry C, Mishkin M, Williamson B, ZHEUTLIN N, Silverman J . Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media. AJR Am J Roentgenol. 1994; 162(3):523-6. DOI: 10.2214/ajr.162.3.8109489. View

10.

Greenberger P, Meyers S, Kramer B . Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography. J Allergy Clin Immunol. 1987; 80(5):698-702. DOI: 10.1016/0091-6749(87)90290-9. View

11.

Greenberger P, Patterson R . The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. 1991; 87(4):867-72. DOI: 10.1016/0091-6749(91)90135-b. View

12.

Witten D . Reactions to urographic contrast media. JAMA. 1975; 231(9):974-7. View

13.

Lang D, Alpern M, Visintainer P, Smith S . Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med. 1991; 115(4):270-6. DOI: 10.7326/0003-4819-115-4-270. View

14.

Lasser E, Berry C, Talner L, SANTINI L, Lang E, Gerber F . Protective effects of corticosteroids in contrast material anaphylaxis. Invest Radiol. 1988; 23 Suppl 1:S193-4. DOI: 10.1097/00004424-198809001-00035. View

15.

Dawson P, Sidhu P . Is there a role for corticosteroid prophylaxis in patients at increased risk of adverse reactions to intravascular contrast agents?. Clin Radiol. 1993; 48(4):225-6. DOI: 10.1016/s0009-9260(05)80300-9. View

16.

Morcos S, Thomsen H . Adverse reactions to iodinated contrast media. Eur Radiol. 2001; 11(7):1267-75. DOI: 10.1007/s003300000729. View

17.

Wysowski D, Nourjah P . Deaths attributed to X-ray contrast media on U.S. death certificates. AJR Am J Roentgenol. 2006; 186(3):613-5. DOI: 10.2214/AJR.04.1790. View

18.

Siegle R . Rates of idiosyncratic reactions. Ionic versus nonionic contrast media. Invest Radiol. 1993; 28 Suppl 5:S95-8; discussion S99. DOI: 10.1097/00004424-199311001-00029. View

19.

Thomsen H, Bush Jr W . Adverse effects of contrast media: incidence, prevention and management. Drug Saf. 1998; 19(4):313-24. DOI: 10.2165/00002018-199819040-00006. View

20.

Kelly J, Patterson R, Lieberman P, Mathison D, Stevenson D . Radiographic contrast media studies in high-risk patients. J Allergy Clin Immunol. 1978; 62(3):181-4. DOI: 10.1016/0091-6749(78)90104-5. View